4 Largecap Fast Revenue Growth and High Margin Stocks to Watch for Future Multibagger Potential: Hindustan Zinc, Torrent Pharma, Cummins India and Indian Hotels

Fast revenue growth and high margin stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Hindustan Zinc, Torrent Pharma, Cummins India and Indian Hotels meet that test, with market caps from Rs 1.12 lakh crore to Rs 2.19 lakh crore and Hindustan Zinc offering the highest return on equity at 61.13%. Each of these companies has FY26 revenue growth of at least 15 per cent and an operating margin of at least 20 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with FY26 revenue growth of at least 15 per cent and an operating margin of at least 20 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening fast revenue growth and high margin stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 30 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Fast Revenue Growth and High Margin Stocks and Why Do They Attract Multibagger Interest?

Fast revenue growth and high margin stocks are shares of large companies that grew sales by fifteen per cent or more in FY26 and still keep at least twenty paise of operating profit from every rupee of sales. The four here cover zinc mining, hotels, pharmaceuticals and engines.

Fast growth with a high margin shows that the company is not buying sales with discounts and has real pricing power, which is a strong base for long term profit growth. For fast revenue growth and high margin stocks, both FY26 and the latest quarter showed growth. Whichever way you read fast revenue growth and high margin stocks, the common thread is rising profit backed by complete financial data. With fast revenue growth and high margin stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for fast revenue growth and high margin stocks are complete. Read each company’s latest results and exchange filings before acting on fast revenue growth and high margin stocks.

Fast Revenue Growth and High Margin Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 30 October 2026. Hindustan Zinc combines the lowest PE of the group, 12.81, with the highest return on equity, 61.13%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Hindustan Zinc	505.80	2,18,709	12.81	12.27	61.13%	0.39	412.25 to 609.05
Torrent Pharmaceuticals	4,613.40	1,75,124	81.23	36.42	25.49%	1.79	3,480.60 to 5,250.00
Cummins India	4,452.60	1,33,661	56.47	45.93	27.87%	0.00	3,883.10 to 6,100.00
Indian Hotels Company	811.65	1,12,493	48.72	36.77	15.97%	0.22	568.70 to 971.00

Hindustan Zinc: Return on Equity of 61.13%

Hindustan Zinc is among the world’s largest integrated zinc producers and also produces lead and silver. It reported FY26 revenue of Rs 41,934 crore, up 19.59% year on year, and net profit of Rs 13,832 crore, up 33.60%. Net profit has compounded at 9.48% a year since FY22, while revenue has grown 8.15% a year. Operating margin was 56.75% in FY26. The debt-to-equity ratio is 0.39.

In the June 2026 quarter, revenue rose 74.70% to Rs 14,063 crore and net profit grew 144.81% to Rs 5,469 crore. Foreign investors raised their holding from 1.31% in September 2025 to 2.36% in September 2026. The stock trades at a PE of 12.81 against an industry PE of 12.27, with a return on equity of 61.13%. The dividend yield is 1.94%.

Torrent Pharma: 28.79% Profit CAGR Since FY22

Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.

The stock trades at a PE of 81.23 against an industry PE of 36.42, with a return on equity of 25.49%. In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 194.63% over five years and 29.72% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026.

Cummins India: 26.11% Profit CAGR Since FY22

Cummins India makes engines and power generation equipment and exports a share of its output. It reported FY26 revenue of Rs 12,660.53 crore, up 16.82% year on year, and net profit of Rs 2,361.75 crore, up 18.09%. Net profit has compounded at 26.11% a year since FY22, while revenue has grown 18.53% a year. Operating margin was 27.15% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 17.19% to Rs 3,563.35 crore and net profit grew 0.89% to Rs 609.30 crore. The share price has gained 408.59% over five years and 16.98% over the past year. Foreign investors raised their holding from 17.50% in June 2025 to 21.19% in June 2026. The stock trades at a PE of 56.47 against an industry PE of 45.93, with a return on equity of 27.87%.

Indian Hotels: Quarterly Profit Up 22.39%

Indian Hotels Company, part of the Tata Group, runs Taj, SeleQtions, Vivanta and Ginger hotels and resorts. It reported FY26 revenue of Rs 9,971.43 crore, up 16.42% year on year, and net profit of Rs 2,195.14 crore, up 11.93%. Revenue has compounded at 32.74% a year since FY22. Operating margin was 35.53% in FY26. The debt-to-equity ratio is 0.22.

The stock trades at a PE of 48.72 against an industry PE of 36.77, with a return on equity of 15.97%. In the June 2026 quarter, revenue rose 15.09% to Rs 2,419.37 crore and net profit grew 22.39% to Rs 390.93 crore. The share price has gained 658.38% over five years. Domestic institutions raised their holding from 18.52% in June 2025 to 24.59% in June 2026.

Fast Revenue Growth and High Margin Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these fast revenue growth and high margin stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
Hindustan Zinc	41,934	13,832	19.59%	8.15%	74.70%	64.19%
Torrent Pharma	13,886.15	2,138.18	20.34%	12.38%	56.29%	33.73%
Cummins India	12,660.53	2,361.75	16.82%	18.53%	17.19%	24.99%
Indian Hotels	9,971.43	2,195.14	16.42%	32.74%	15.09%	32.19%

Check the Univest Screener for live data on these fast revenue growth and high margin stocks

Institutional Holding in Hindustan Zinc, Torrent Pharma, Cummins India and Indian Hotels

Institutional holding shows who is backing these fast revenue growth and high margin stocks alongside the promoter. The table uses the latest reported quarter for each. Indian Hotels has the deepest institutional backing, with FII and DII together holding 46.30% as of June 2026. Domestic institutions increased their holding over the past year in Torrent Pharma (from 9.28% to 12.87%) and Indian Hotels (from 18.52% to 24.59%).

Stock	Promoter	FII	DII	Public	Quarter
Hindustan Zinc	60.71%	2.36%	4.85%	32.07%	September 2026
Torrent Pharma	60.78%	17.97%	12.87%	8.38%	July 2026
Cummins India	51.00%	21.19%	19.16%	8.66%	June 2026
Indian Hotels	38.12%	21.71%	24.59%	15.58%	June 2026

Risks to Weigh in Fast Revenue Growth and High Margin Stocks

Being careful with fast revenue growth and high margin stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Torrent Pharma trades at a PE of 81.23 against an industry PE of 36.42, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Fast Revenue Growth and High Margin Stocks

Picking from fast revenue growth and high margin stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (12.27 to 45.93) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Hindustan Zinc, Torrent Pharma, Cummins India and Indian Hotels live prices.

Conclusion

Among fast revenue growth and high margin stocks, Hindustan Zinc stands out for the highest return on equity at 61.13%, Torrent Pharma for the fastest profit growth, 28.79% a year since FY22, Cummins India for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.00 and Indian Hotels for the biggest five-year price gain at 658.38%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing fast revenue growth and high margin stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Fast Revenue Growth and High Margin Stocks to Watch

Which are the best fast revenue growth and high margin stocks to watch for multibagger potential?

Ans. Hindustan Zinc, Torrent Pharma, Cummins India and Indian Hotels are the 4 names this list highlights, with market caps of Rs 2,18,709 crore, Rs 1,75,124 crore, Rs 1,33,661 crore and Rs 1,12,493 crore respectively. Hindustan Zinc is notable for the highest return on equity at 61.13%. Torrent Pharma stands out for the fastest profit growth, 28.79% a year since FY22. Cummins India offers a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.00. Indian Hotels brings the biggest five-year price gain at 658.38%. These are watchlist names for fast revenue growth and high margin stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Hindustan Zinc a good stock for long-term investors?

Ans. Hindustan Zinc has a return on equity of 61.13%, a PE of 12.81 against an industry PE of 12.27 and a market cap of Rs 2,18,709 crore. Net profit has compounded at 9.48% a year since FY22, and FY26 revenue rose 19.59% while June 2026 quarter net profit grew 144.81%. Long-term returns in fast revenue growth and high margin stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Torrent Pharma become a multibagger from here?

Ans. Torrent Pharma has already gained 194.63% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in fast revenue growth and high margin stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 28.79% a year since FY22, and FY26 revenue rose 20.34%. At a PE of 81.23 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of Hindustan Zinc, Torrent Pharma, Cummins India and Indian Hotels?

Ans. As of 30 October 2026, Hindustan Zinc has a market cap of Rs 2,18,709 crore, Torrent Pharma has a market cap of Rs 1,75,124 crore, Cummins India has a market cap of Rs 1,33,661 crore and Indian Hotels has a market cap of Rs 1,12,493 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on fast revenue growth and high margin stocks.

What are the risks of investing in fast revenue growth and high margin stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Torrent Pharma trades at a PE of 81.23 against an industry PE of 36.42, so earnings growth needs to hold up.

Why is Torrent Pharma trading at a PE of 81.23?

Ans. Torrent Pharma’s PE of 81.23 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 25.49%, profit growth of 28.79% a year since FY22 and FY26 revenue growth of 20.34%, which also means the stock is more sensitive if growth slows. Investors in fast revenue growth and high margin stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Hindustan Zinc, Torrent Pharma, Cummins India and Indian Hotels?

Ans. As of the latest reported quarter, FII and DII together hold 7.21% of Hindustan Zinc (2.36% and 4.85%), 30.84% of Torrent Pharma (17.97% and 12.87%), 40.35% of Cummins India (21.19% and 19.16%) and 46.30% of Indian Hotels (21.71% and 24.59%). Rising institutional holding is a useful signal in fast revenue growth and high margin stocks, though it should be read with earnings trends rather than on its own.